0001973379-24-000095.txt : 20240305 0001973379-24-000095.hdr.sgml : 20240305 20240305094732 ACCESSION NUMBER: 0001973379-24-000095 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240305 DATE AS OF CHANGE: 20240305 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Ascendis Pharma A/S CENTRAL INDEX KEY: 0001612042 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-36815 FILM NUMBER: 24718549 BUSINESS ADDRESS: STREET 1: TUBORG BOULEVARD 12 CITY: HELLERUP STATE: G7 ZIP: DK-2900 BUSINESS PHONE: 45 70 22 22 44 MAIL ADDRESS: STREET 1: TUBORG BOULEVARD 12 CITY: HELLERUP STATE: G7 ZIP: DK-2900 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Cha Albert CENTRAL INDEX KEY: 0001397906 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 505 HAMILTON AVENUE, SUITE 200 CITY: PALO ALTO STATE: CA ZIP: 94301 FORMER COMPANY: FORMER CONFORMED NAME: CHA ALBERT DATE OF NAME CHANGE: 20070427 144 1 primary_doc.xml 144 0001397906 XXXXXXXX LIVE 0001612042 Ascendis Pharma A/S 001-36815 TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44 Cha Albert Director Ordinary Shares Citigroup Global Markets Inc.

390 Greenwich Street New York NY 10013

658 98700.00 57707439 03/01/2024 NASDAQ Ordinary Shares 03/01/2024 Restricted Stock Vesting Ascendis Pharma A/S N 1166 03/01/2024 Services Rendered Y The sales were completed according to 10B5-1 plans entered into in September 2023, for the sale of shares in connection to RSUs and PSUs vesting. 03/04/2024 Conformed Signature On File